Inside the race to put computers in the human brain

What happened
Neuralink has developed the N1 brain-computer interface implant, which is currently being tested by about 26 people with severe disabilities. The device is surgically implanted onto the brain and allows users to control electronic devices using neural signals. Neuralink, founded by Elon Musk in 2016, is seeking broader adoption and is part of a competitive industry where several companies are racing to secure FDA approval for similar brain-computer interface products. The technology is not yet available for public sale in the United States, but the field is rapidly advancing.
Key details
- Neuralink's N1 implant uses 64 ultra-thin wires with electrodes to detect brain activity.
- The device transmits neural data to a phone or tablet, enabling users to interact with technology hands-free.
- Neuralink has received $1.3 billion in funding and was valued at about $9.7 billion by 2025.
- Rival companies include Synchron, which has implanted its device in 15 people, and Paradromics, focusing on speech restoration.
- Privacy concerns have been raised about the potential for these devices to access and transmit users' thoughts and feelings.
Why it matters
People with severe disabilities may soon have new ways to interact with technology, potentially improving their independence and quality of life. Companies in the brain-computer interface sector are competing for a large market and regulatory approval, which could lead to the first commercial brain implants in the U.S. The collection and use of neural data by these devices introduce new privacy risks for users, as companies could gain access to sensitive personal information.
